Your browser doesn't support javascript.
loading
A Phase II Study with Lead-In Safety Cohort of 5-Fluorouracil, Oxaliplatin, and Lapatinib in Combination with Radiation Therapy as Neoadjuvant Treatment for Patients with Localized HER2-Positive Esophagogastric Adenocarcinomas.
Shepard, Gregg; Arrowsmith, Edward R; Murphy, Patrick; Barton, John H; Peyton, James D; Mainwaring, Mark; Blakely, Laura; Maun, Noel A; Bendell, Johanna C.
Afiliação
  • Shepard G; Sarah Cannon Research Institute, Nashville, Tennessee, USA.
  • Arrowsmith ER; Tennessee Oncology, PLLC, Nashville, Tennessee, USA.
  • Murphy P; Sarah Cannon Research Institute, Nashville, Tennessee, USA.
  • Barton JH; Tennessee Oncology, PLLC, Nashville, Tennessee, USA.
  • Peyton JD; Sarah Cannon Research Institute, Nashville, Tennessee, USA.
  • Mainwaring M; Tennessee Oncology, PLLC, Nashville, Tennessee, USA.
  • Blakely L; Sarah Cannon Research Institute, Nashville, Tennessee, USA.
  • Maun NA; Tennessee Oncology, PLLC, Nashville, Tennessee, USA.
  • Bendell JC; Sarah Cannon Research Institute, Nashville, Tennessee, USA.
Oncologist ; 22(10): 1152-e98, 2017 10.
Article em En | MEDLINE | ID: mdl-28765502

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos Organoplatínicos / Quinazolinas / Neoplasias Gástricas / Neoplasias Esofágicas / Terapia Neoadjuvante / Fluoruracila Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos Organoplatínicos / Quinazolinas / Neoplasias Gástricas / Neoplasias Esofágicas / Terapia Neoadjuvante / Fluoruracila Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article